Severe fever and thrombocytopenia syndrome virus infection: Considerations for vaccine evaluation of a rare disease

Severe fever and thrombocytopenia syndrome virus infection: Considerations for vaccine evaluation of a rare disease

Infection caused by the severe fever and thrombocytopenia syndrome virus (SFTSV) causes a hemorrhagic illness with a mortality between 20% and 40%. Initially recognized in 2009 in China, cases have additionally been documented in Japan and Korea although retrospective studies have documented seropre...

Full description

Bibliographic Details
Main Authors: Joel N. Maslow, Jackie J. Kwon, Susan K. Mikota, Susan Spruill, Youngran Cho, Moonsup Jeong
Format: Article
Language:English
Published: Taylor & Francis Group 2019-10-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
sfts virus
severe fever and thrombocytopenia virus
emerging infectious disease
rare disease
clinical trial design
sample size estimate
seroprevalence
Online Access:http://dx.doi.org/10.1080/21645515.2019.1633875

Internet

http://dx.doi.org/10.1080/21645515.2019.1633875

Similar Items